Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Free Cash Flow Generation Index
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Free Cash Flow Generation Index of 0.91x as of June 2025. Free cash flow of CN¥163.30 Million represents 1% of operating cash flow (CN¥178.57 Million). Explore Hubei Jumpcan Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hubei Jumpcan Pharmaceutical Co Ltd Free Cash Flow Generation Index (2000–2025)
Historical FCF Generation Index trend for Hubei Jumpcan Pharmaceutical Co Ltd across 25 annual periods. For the full cash flow conversion analysis, see Hubei Jumpcan Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Free Cash Flow Generation for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Year-by-year Free Cash Flow Generation Index for Hubei Jumpcan Pharmaceutical Co Ltd. Check Hubei Jumpcan Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.92x | CN¥1.10 Billion | CN¥1.20 Billion | CN¥95.86 Million | ▲ +0.0% |
| 2024 | 0.92x | CN¥2.00 Billion | CN¥2.18 Billion | CN¥174.34 Million | ▲ +0.8% |
| 2023 | 0.91x | CN¥3.16 Billion | CN¥3.46 Billion | CN¥301.64 Million | ▲ +0.6% |
| 2022 | 0.91x | CN¥2.38 Billion | CN¥2.62 Billion | CN¥243.66 Million | ▲ +4.4% |
| 2021 | 0.87x | CN¥1.65 Billion | CN¥1.89 Billion | CN¥248.32 Million | ▲ +14.5% |
| 2020 | 0.76x | CN¥1.35 Billion | CN¥1.78 Billion | CN¥429.63 Million | ▲ +1.8% |
| 2019 | 0.75x | CN¥1.60 Billion | CN¥2.15 Billion | CN¥546.44 Million | ▲ +22.4% |
| 2018 | 0.61x | CN¥1.04 Billion | CN¥1.71 Billion | CN¥668.06 Million | ▲ +63.6% |
| 2017 | 0.37x | CN¥442.50 Million | CN¥1.19 Billion | CN¥746.25 Million | ▼ -42.4% |
| 2016 | 0.65x | CN¥589.60 Million | CN¥913.10 Million | CN¥323.49 Million | ▲ +67.1% |
| 2015 | 0.39x | CN¥249.50 Million | CN¥645.48 Million | CN¥395.98 Million | ▼ -24.3% |
| 2014 | 0.51x | CN¥314.60 Million | CN¥616.11 Million | CN¥301.51 Million | ▲ +759.4% |
| 2013 | 0.06x | CN¥17.06 Million | CN¥287.16 Million | CN¥270.10 Million | ▲ +109.1% |
| 2012 | -0.65x | CN¥-17.66 Million | CN¥27.01 Million | CN¥44.67 Million | ▲ +99.6% |
| 2011 | -146.69x | CN¥-60.33 Million | CN¥411.24K | CN¥60.74 Million | ▼ -29461.1% |
| 2010 | -0.50x | CN¥-25.37 Million | CN¥51.13 Million | CN¥76.50 Million | ▼ -7.5% |
| 2009 | -0.46x | CN¥-2.27 Million | CN¥4.92 Million | CN¥7.19 Million | ▼ -172.3% |
| 2008 | 0.64x | CN¥14.72 Million | CN¥23.05 Million | CN¥8.33 Million | ▼ -18.8% |
| 2007 | 0.79x | CN¥28.89 Million | CN¥36.72 Million | CN¥7.83 Million | ▲ +107.0% |
| 2006 | -11.22x | CN¥-47.59 Million | CN¥4.24 Million | CN¥51.83 Million | ▼ -19978.9% |
| 2005 | 0.06x | CN¥3.58 Million | CN¥63.38 Million | CN¥59.80 Million | ▲ +100.3% |
| 2003 | -16.83x | CN¥-37.75 Million | CN¥2.24 Million | CN¥39.99 Million | ▼ -289.3% |
| 2002 | -4.32x | CN¥-95.09 Million | CN¥22.00 Million | CN¥117.09 Million | ▲ +60.2% |
| 2001 | -10.86x | CN¥-80.65 Million | CN¥7.43 Million | CN¥88.07 Million | ▼ -6075.4% |
| 2000 | 0.18x | CN¥4.31 Million | CN¥23.73 Million | CN¥19.41 Million | — |